Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 06:35 am Purchase | 2021-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN | Artal International S.C.A. | 138,956 6.400% | 48,077 (+52.90%) | Filing History |
| 2022-02-09 09:31 am Purchase | 2021-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN | MFN Partners LP | 169,461 7.800% | 169,461 (New Position) | Filing History |
| 2022-02-09 09:11 am Sale | 2022-02-08 | 13G | Cyclerion Therapeutics, Inc. CYCN | FMR LLC | 130,871 6.042% | -5,115 (-3.76%) | Filing History |
| 2021-06-07 5:21 pm Purchase | 2021-06-03 | 13D | Cyclerion Therapeutics, Inc. CYCN | Hecht Peter M | 179,833 8.600% | 41,159 (+29.68%) | Filing History |
| 2021-05-14 4:56 pm Purchase | 2021-05-04 | 13D | Cyclerion Therapeutics, Inc. CYCN | Hecht Peter M | 138,675 7.800% | 138,675 (New Position) | Filing History |
| 2021-02-12 8:55 pm Sale | 2020-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN | Artal International S.C.A. | 90,879 5.400% | -2,200 (-2.36%) | Filing History |
| 2021-02-12 5:09 pm Purchase | 2020-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN | MFN Partners Management LP | 121,384 7.150% | 46,990 (+63.16%) | Filing History |
| 2021-02-08 10:19 am Purchase | 2021-02-05 | 13G | Cyclerion Therapeutics, Inc. CYCN | FMR LLC | 135,986 8.008% | 9,412 (+7.44%) | Filing History |
| 2021-02-05 11:24 am Unchanged | 2020-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN | American Endowment Foundation | 133,027 7.800% | 0 (Unchanged) | Filing History |
| 2020-09-09 3:52 pm Sale | 2020-08-31 | 13G | Cyclerion Therapeutics, Inc. CYCN | BlackRock Inc. BLK | 79,095 4.700% | -1,739 (-2.15%) | Filing History |
| 2020-08-10 4:16 pm Purchase | 2020-07-31 | 13G | Cyclerion Therapeutics, Inc. CYCN | Slate Path Capital LP | 309,803 18.300% | 309,803 (New Position) | Filing History |